Phillips-Medisize will be exhibiting at the Drug Delivery to the Lungs Conference in Scotland next month, providing a chance to further tout its respiratory device capabilities.

The Hudson, Wis.–based contract manufacturer boasts more than 30 years at the forefront of inhalation technology. The company’s experience ranges from feasibility to selecting the right components – all the way through to commercial scale production, including electronics integration.

Phillips-Medisize will also highlight connected health products and services, which involve the complete integration of respiratory devices, connected services and drugs.

“We continue to be very focused on partnerships built on innovation, as well as our continuum of contract services for digital interfaces to maximize the patient and caregiver experience. With the acquisition by Molex, we also vertically integrating electronics into our existing capabilities on respiratory devices,” Phillips-Medisize CTO Bill Welch said in a news release.

The Drug Delivery to the Lungs Conference is Dec. 6–8 at the Edinburgh International Conference Center.